Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23715022 | 0.91 | HTR2A (0.41) | HTR2AHTR2CHTR2BMTNR1ANQO2 | |
| SCHEMBL15897044 | 0.89 | CAMK2A (0.45) | KMT2ALMNAMAPTSLC6A4SLC6A3 | |
| SCHEMBL5847603 | 0.83 | MTNR1A (0.54) | MTNR1ANQO2MTNR1B | |
| SCHEMBL24542973 | 0.83 | LMNA (0.43) | KMT2ALMNAHTR2AHTR2CHTR2B | |
| SCHEMBL29673142 | 0.83 | LMNA (0.43) | KMT2ALMNAHTR2AHTR2CHTR2B | |
| SCHEMBL14059338 | 0.82 | KMT2A (0.39) | KMT2ALMNAHTR2AHTR2CHTR2B | |
| SCHEMBL14059398 | 0.82 | TDP1 (0.38) | KMT2AMAPTSLC6A4SLC6A3MEN1 | |
| SCHEMBL3353429 | 0.81 | SIRT1 (0.44) | KMT2ALMNAHTR2AHTR2CHTR2B | |
| SCHEMBL1530291 | 0.79 | SRD5A1 (0.44) | MAPTSLC6A4SLC6A3 | |
| SCHEMBL30436687 | 0.79 | SRD5A1 (0.44) | MAPTSLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354319-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | UNIV CORNELL (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354319-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | CALCOCO2, MDN1, MBNL1 | KMT2A 4317/4885LMNA 1549/4885HTR2A 4480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.